je.st
news
Pfizer, FDA in talks on prescription details for key breast cancer drug
2015-01-08 18:21:28| Biotech - Topix.net
Pfizer Inc said Thursday it has begun talks with the U.S. Food and Drug Administration to finalize the prescription label of its breast cancer drug palbociclib, in an indication the drug was likely closer to regulatory approval. The largest U.S. drugmaker also said there was no plan for the agency to hold an advisory committee meeting to discuss the medicine prior to an approval decision.
Tags: details
key
drug
cancer
Category:Biotechnology and Pharmaceuticals